Phase I Evaluation and Pharmacokinetics of Tiazofurin (2-β-D-Ribofuranosylthiazole-4-carboxamide, NSC 286193)

Teresa J. Melink, Daniel D. Von Hoff, John G. Kuhn, Maria R. Hersh, Lawrence A. Sternson, Thomas F. Patton, Robert Siegler, David H. Boldt, Gary M. Clark

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I Evaluation and Pharmacokinetics of Tiazofurin (2-β-D-Ribofuranosylthiazole-4-carboxamide, NSC 286193)'. Together they form a unique fingerprint.

Medicine & Life Sciences